Pfizer wins latest round in Chinese Viagra dispute

Pfizer wins latest round in Chinese Viagra dispute

When the patent relating to Viagrawas invalidated in China, it createdheadlines across the world. But asthe latest decision in the caseshows, the dispute is actually anexample of the country’s IP systemfunctioning properly

Download

Unlock unlimited access to all IAM content